Cargando…
Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients?
BACKGROUND: New data indicates that vancomycin may be less effective against methicillin-resistant Staphylococcus aureus (MRSA) infections with minimum inhibition concentration (MIC) within a sensitive range. OBJECTIVES: The aim of this study was to determine the distribution of the vancomycin MIC b...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295319/ https://www.ncbi.nlm.nih.gov/pubmed/25632329 http://dx.doi.org/10.5812/jjm.12831 |
_version_ | 1782352825334890496 |
---|---|
author | Aminzadeh, Zohreh Yadegarynia, Davood Fatemi, Alireza Tahmasebian Dehkordi, Elham Azad Armaki, Saeed |
author_facet | Aminzadeh, Zohreh Yadegarynia, Davood Fatemi, Alireza Tahmasebian Dehkordi, Elham Azad Armaki, Saeed |
author_sort | Aminzadeh, Zohreh |
collection | PubMed |
description | BACKGROUND: New data indicates that vancomycin may be less effective against methicillin-resistant Staphylococcus aureus (MRSA) infections with minimum inhibition concentration (MIC) within a sensitive range. OBJECTIVES: The aim of this study was to determine the distribution of the vancomycin MIC between MRSA strains and observe the difference in mortality between patients, while the influence of changes in MIC on the efficacy of vancomycin was also examined. PATIENTS AND METHODS: A routine date-based study was conducted on 41 MRSA isolates in a hospital in Tehran, Iran. The isolates were assessed for MIC by using the E-test method, and results were categorized into three groups: A (MIC < 1.5 μg/mL), B (1.5 ≤ MIC < 2 μg/mL) and C (MIC ≥ 2 μg/mL) MRSA. RESULTS: Group A was the most common group, followed by groups C and B. Although there was no statistically significant difference between patients’ mortality with the MIC group, the mortality rate of group A was higher than C and B. CONCLUSIONS: Regarding Clinical and Laboratory Standards Institute (CLSI) definition for vancomycin susceptibility (MIC < 2 μg/mL), it seems that vancomycin may not be considered as the best antibiotic in order to treat heteroresistant vancomycin intermediate S. aureus (hVISA) and vancomycin sensitive S. aureus (VSSA) infections, and a new breakpoint for vancomycin and alternative antibiotics should be considered. |
format | Online Article Text |
id | pubmed-4295319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-42953192015-01-28 Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients? Aminzadeh, Zohreh Yadegarynia, Davood Fatemi, Alireza Tahmasebian Dehkordi, Elham Azad Armaki, Saeed Jundishapur J Microbiol Brief Report BACKGROUND: New data indicates that vancomycin may be less effective against methicillin-resistant Staphylococcus aureus (MRSA) infections with minimum inhibition concentration (MIC) within a sensitive range. OBJECTIVES: The aim of this study was to determine the distribution of the vancomycin MIC between MRSA strains and observe the difference in mortality between patients, while the influence of changes in MIC on the efficacy of vancomycin was also examined. PATIENTS AND METHODS: A routine date-based study was conducted on 41 MRSA isolates in a hospital in Tehran, Iran. The isolates were assessed for MIC by using the E-test method, and results were categorized into three groups: A (MIC < 1.5 μg/mL), B (1.5 ≤ MIC < 2 μg/mL) and C (MIC ≥ 2 μg/mL) MRSA. RESULTS: Group A was the most common group, followed by groups C and B. Although there was no statistically significant difference between patients’ mortality with the MIC group, the mortality rate of group A was higher than C and B. CONCLUSIONS: Regarding Clinical and Laboratory Standards Institute (CLSI) definition for vancomycin susceptibility (MIC < 2 μg/mL), it seems that vancomycin may not be considered as the best antibiotic in order to treat heteroresistant vancomycin intermediate S. aureus (hVISA) and vancomycin sensitive S. aureus (VSSA) infections, and a new breakpoint for vancomycin and alternative antibiotics should be considered. Kowsar 2014-10-01 2014-10 /pmc/articles/PMC4295319/ /pubmed/25632329 http://dx.doi.org/10.5812/jjm.12831 Text en Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences; Published by Kowsar Corp. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Aminzadeh, Zohreh Yadegarynia, Davood Fatemi, Alireza Tahmasebian Dehkordi, Elham Azad Armaki, Saeed Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients? |
title | Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients? |
title_full | Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients? |
title_fullStr | Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients? |
title_full_unstemmed | Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients? |
title_short | Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients? |
title_sort | vancomycin minimum inhibitory concentration for methicillin-resistant staphylococcus aureus infections; is there difference in mortality between patients? |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295319/ https://www.ncbi.nlm.nih.gov/pubmed/25632329 http://dx.doi.org/10.5812/jjm.12831 |
work_keys_str_mv | AT aminzadehzohreh vancomycinminimuminhibitoryconcentrationformethicillinresistantstaphylococcusaureusinfectionsistheredifferenceinmortalitybetweenpatients AT yadegaryniadavood vancomycinminimuminhibitoryconcentrationformethicillinresistantstaphylococcusaureusinfectionsistheredifferenceinmortalitybetweenpatients AT fatemialireza vancomycinminimuminhibitoryconcentrationformethicillinresistantstaphylococcusaureusinfectionsistheredifferenceinmortalitybetweenpatients AT tahmasebiandehkordielham vancomycinminimuminhibitoryconcentrationformethicillinresistantstaphylococcusaureusinfectionsistheredifferenceinmortalitybetweenpatients AT azadarmakisaeed vancomycinminimuminhibitoryconcentrationformethicillinresistantstaphylococcusaureusinfectionsistheredifferenceinmortalitybetweenpatients |